peter attia on semaglutide A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% Combining Semaglutide and Muscle Growth:

& Pastor, R

Besides lowering blood glucose, Semaglutide decreases body weight and systolic blood pressure [7], but it increases the risk of nausea, vomiting and diarrhoea [7, 8]

RegenCen provides physician-guided testosterone therapy designed to restore levels to a healthy physiologic range while monitoring long-term health and treatment response

SeekPeptides members gain access to comprehensive troubleshooting guides that cover these scenarios in detail, along with community insights from experienced researchers who have navigated similar challenges

Facing steep losses from GLP-1 costs, both insurers shed hundreds of employees from their workforces last year

FEBS Letters 1988;238:343 Pickart L et al